Table 3

Worry, concern and reassurance at 6 months and 12 months*

6-month follow-up12-month follow-up
Higher worry
(n=757)
Higher concern
(n=758)
Higher reassurance
(n=756)
Higher worry
(n=533)
Higher concern
(n=533)
Higher reassurance
(n=529)
Control†
 n (%)43 (11.9)8 (2.2)333 (92.2)36 (13.6)10 (3.8)237 (89.4)
 OR (95% CI)*Reference 0.4 (0.2 to 0.8) 5.9 (3.5 to 9.8) Reference 0.3 (0.1 to 0.6) 2.8 (1.5 to 5.0)
HPV positive, normal
 n (%)51 (29.3)36 (20.7)71 (41.0)36 (33.3)24 (22.2)66 (62.9)
 OR (95% CI)*1.7 (0.9 to 3.1)ReferenceReference2.2 (1.3 to 3.7)ReferenceReference
HPV positive, abnormal
 n (%)35 (32.7)22 (20.6)60 (56.6)21 (28.8)17 (23.3)47 (64.4)
 OR (95% CI)*1.8 (0.9 to 3.6)0.6 (0.3 to 1.5)1.8 (1.0 to 3.1) 1.8 (0.9 to 3.7) 0.8 (0.4 to 1.7)1.1 (0.6 to 2.0)
HPV persistent
 n (%)41 (35.3)23 (19.8)61 (52.6)27 (31.0)18 (20.7)54 (62.8)
 OR (95% CI)* 2.00 (1.1 to 3.7) 0.8 (0.4 to 1.6)1.5 (0.8 to 2.6) 2.00 (1.1 to 3.5) 0.8 (0.4 to 1.5)1.0 (0.6 to 1.8)
  • Logistic regression models, fully adjusted for age, marital status, ethnicity, Index of Multiple Deprivation, education, number of previous screens and NHS site.

  • Bolded ORs are statistically significant.

  • *OR (95% CI) of having higher worry, higher concern or higher reassurance.

  • †Includes women not tested for HPV, HPV negative, HPV cleared.

  • HPV, human papillomavirus; NHS, National Health Service.